Zepp Health Corp Files November 2024 6-K Report
Ticker: ZEPP · Form: 6-K · Filed: Nov 19, 2024 · CIK: 1720446
Sentiment: neutral
Topics: regulatory-filing, 6-K, press-release
Related Tickers: ZEPP
TL;DR
Zepp Health (ZEPP) filed its monthly 6-K, including a press release. Standard disclosure.
AI Summary
Zepp Health Corporation, formerly Huami Corp, filed a Form 6-K on November 19, 2024. This report is for the month of November 2024 and indicates the company is a foreign private issuer filing under the 1934 Act. The filing includes a press release as Exhibit 99.1.
Why It Matters
This filing provides routine updates and regulatory disclosures for Zepp Health Corporation, a publicly traded company, ensuring transparency for investors.
Risk Assessment
Risk Level: low — This filing is a routine 6-K report and does not contain significant new financial or operational information that would alter the company's risk profile.
Key Players & Entities
- Zepp Health Corporation (company) — Registrant
- Huami Corp (company) — Former Company Name
- November 19, 2024 (date) — Filing Date
- Exhibit 99.1 (document) — Included Press Release
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the issuer has made or is required to make public pursuant to the laws of its home country or that it has filed or is required to file with a stock exchange.
When was Zepp Health Corporation formerly known as?
Zepp Health Corporation was formerly known as Huami Corp.
What is the filing date of this Form 6-K?
This Form 6-K was filed on November 19, 2024.
What is included as an exhibit in this filing?
Exhibit 99.1, a Press Release, is included in this filing.
What is the primary business address of Zepp Health Corporation?
The primary business address is Huami Global Innovation Center, Building B2, Zhong'an Chuanggu Technology Park, No. 900 Wangjiang West Road, Hefei, 230088, People's Republic of China.
Filing Stats: 151 words · 1 min read · ~1 pages · Grade level 13.1 · Accepted 2024-11-19 06:01:53
Filing Documents
- tm2428712d1_6k.htm (6-K) — 9KB
- tm2428712d1_ex99-1.htm (EX-99.1) — 200KB
- 0001104659-24-120316.txt ( ) — 210KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2024 Commission File Number: 001-38369 Zepp Health Corporation (Registrant’s Name) Huami Global Innovation Center Building B2, Zhong’an Chuanggu Technology Park No. 900 Wangjiang West Road Hefei, 230088 People’s Republic of China (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Exhibit Index Exhibit 99.1 – Press Release SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Zepp Health Corporation By: /s/ Leon Deng Name: Leon Deng Title: Chief Financial Officer Date: November 19, 2024